Literature DB >> 18661397

Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.

Cristina Prat1, Juan Manuel Sancho, Josep Dominguez, Blanca Xicoy, Montse Gimenez, Christelle Ferra, Silvia Blanco, Alicia Lacoma, Josep Maria Ribera, Vicenc Ausina.   

Abstract

Infectious complications in neutropenic patients are a major cause of morbidity and mortality. Clinical signs are unspecific and fever can be attributed to other causes. Inflammatory biomarkers have emerged as potentially useful in diagnosis of bacterial and fungal infection. Levels of several biomarkers were measured in patients with hematological malignancy at diagnosis and at the beginning of neutropenia due to cytostatic treatment or after hematopoietic stem cell transplantation, and daily until 6 days after presenting fever. Procalcitonin (PCT) and neopterin levels were not elevated at diagnosis or at the beginning of neutropenia. C-reactive protein (CRP) was moderately elevated. PCT levels were significantly higher in patients with Gram-negative bacteremia at 24-48 h after the onset of fever. Patients with probable fungal infection presented elevated PCT values when fever persisted for more than 4-5 days. CRP was more sensitive to predict bacteremia (both Gram-positive and Gram-negative) but the specificity was low. Neither neopterin, IL-6 nor IL-8 presented significant differences according to the origin or etiology of fever. Since it showed a high negative predictive value of Gram-negative bacteremia, clinical prediction rules that attempt to predict a high risk of severe infection might be improved by including measurement of PCT.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18661397     DOI: 10.1080/10428190802258956

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  26 in total

1.  Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome.

Authors:  Maria F Ibarra; Marisa Klein-Gitelman; Elaine Morgan; Maria Proytcheva; Christine Sullivan; Gabrielle Morgan; Lauren M Pachman; Maurice R G O'Gorman
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

2.  Gene immunotherapy of chronic lymphocytic leukemia: a phase I study of intranodally injected adenovirus expressing a chimeric CD154 molecule.

Authors:  Januario E Castro; Johanna Melo-Cardenas; Mauricio Urquiza; Juan S Barajas-Gamboa; Ramin S Pakbaz; Thomas J Kipps
Journal:  Cancer Res       Date:  2012-04-13       Impact factor: 12.701

Review 3.  Use of plasma procalcitonin levels as an adjunct to clinical microbiology.

Authors:  David N Gilbert
Journal:  J Clin Microbiol       Date:  2010-04-26       Impact factor: 5.948

4.  Biomarker candidates for the detection of an infectious etiology of febrile neutropenia.

Authors:  Martin E Richter; Sophie Neugebauer; Falco Engelmann; Stefan Hagel; Katrin Ludewig; Paul La Rosée; Herbert G Sayer; Andreas Hochhaus; Marie von Lilienfeld-Toal; Tom Bretschneider; Christine Pausch; Christoph Engel; Frank M Brunkhorst; Michael Kiehntopf
Journal:  Infection       Date:  2015-08-15       Impact factor: 3.553

5.  Value of lipopolysaccharide binding protein as diagnostic marker of infection in adult cancer patients with febrile neutropenia: comparison with C-reactive protein, procalcitonin, and interleukin 6.

Authors:  Luis García de Guadiana-Romualdo; Ignacio Español-Morales; Pablo Cerezuela-Fuentes; Luciano Consuegra-Sánchez; Ana Hernando-Holgado; Patricia Esteban-Torrella; Enrique Jiménez-Santos; Monserrat Viqueira-González; África de Béjar-Almira; María Dolores Albaladejo-Otón
Journal:  Support Care Cancer       Date:  2015-01-07       Impact factor: 3.603

6.  Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.

Authors:  Daniel Molano Franco; Ingrid Arevalo-Rodriguez; Marta Roqué I Figuls; Nadia G Montero Oleas; Xavier Nuvials; Javier Zamora
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

Review 7.  Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis.

Authors:  Chun-Wei Wu; Jiunn-Yih Wu; Chun-Kuei Chen; Shiau-Ling Huang; Shou-Chien Hsu; Meng-Tse Gabriel Lee; Shy-Shin Chang; Chien-Chang Lee
Journal:  Support Care Cancer       Date:  2015-02-21       Impact factor: 3.603

8.  Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia.

Authors:  Mizuki Aimoto; Hideo Koh; Takako Katayama; Hiroshi Okamura; Takuro Yoshimura; Shiro Koh; Satoru Nanno; Mitsutaka Nishimoto; Asao Hirose; Mika Nakamae; Takahiko Nakane; Hirohisa Nakamae; Hiroshi Kakeya; Masayuki Hino
Journal:  Infection       Date:  2014-07-20       Impact factor: 3.553

9.  Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock.

Authors:  Xiao-Jun Xu; Yong-Min Tang; Chan Liao; Hua Song; Shi-Long Yang; Wei-Qun Xu; Shu-Wen Shi; Ning Zhao
Journal:  Intensive Care Med       Date:  2012-11-21       Impact factor: 17.440

10.  Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid.

Authors:  Tobias Weissenbacher; Rüdiger P Laubender; Steven S Witkin; Andrea Gingelmaier; Barbara Schiessl; Franziskus Kainer; Klaus Friese; Udo Jeschke; Darius Dian; Katrin Karl
Journal:  BMC Res Notes       Date:  2012-07-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.